CHAPTER 80 Management of Native Valve Endocarditis
Endocarditis of a patient’s native heart valve is defined as native valve endocarditis (NVE). The incidence of NVE in developed countries is approximately 1.7 to 7.0 cases per 100,000 persons per year, and it is highest among older adults.1–3 NVE typically affects the left heart, with right heart involvement observed in only 5% to 10% of all cases.3,4 Although the overall incidence of NVE has remained consistent over the past several decades, the causes and risk factors for NVE have changed in recent years from being primarily rheumatic heart disease to being degenerative valve disease, intravenous drug use, intravascular devices, and nosocomial infections.
PATHOLOGY
Two conditions must be present for the development of nearly all cases of NVE: endocardial injury causing a disruption of the valvular endocardial surface, and subsequent infiltration of the injured site by blood-borne microorganisms, typically bacteria.5 Endocardial trauma results from degenerative calcific changes, rheumatic disease, mitral valve prolapse, regurgitant jet flow, congenital abnormalities (e.g., bicuspid aortic valve), or iatrogenic etiologies (e.g., cardiac catheterization). Endocardial injury results in the deposition of platelet-fibrin products, which then serve as a nidus for the attachment of microorganisms. Organisms that cause NVE enter the bloodstream through compromise of the skin, mucosal surfaces, or other sites of focal infection. Common causes of bacteremia or fungemia that predispose to NVE include intravenous drug use, indwelling catheters, debilitated condition, medical procedures, and even simple events such as tooth brushing and mastication.5–7
MICROBIOLOGY
Endocarditis is caused principally by staphylococci and streptococci. The most common agents are Staphylococcus aureus (32%), viridans group streptococci (18%), enterococci (11%), coagulase-negative staphylococci (11%), and Streptococcus bovis (7%).8,9 Gram-negative bacteria can also cause NVE and are classified into either the HACEK group (fastidious gram-negative bacilli including Haemophilus aphrophilus, Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, and Kingella kingae) or non-HACEK group, with each accounting for approximately 2% of all cases. These organisms require a prolonged incubation period before growth and are often resistant to many antibiotics. Fungal NVE, usually caused by Candida albicans or Aspergillus fumigatus, is rare but can lead to devastating complications.10,11
The microbiology of NVE differs somewhat depending on individual risk factors and demographics. For example, viridans group streptococci are more prevalent in community-acquired endocarditis, whereas the more virulent S. aureus is more common in nosocomial cases.1–38 NVE of the right heart is predominantly a disease of injection drug users, and in this population native tricuspid valve endocarditis caused by S. aureus is the predominant form of the disease.4
Approximately 2% to 7% of NVE cases are deemed culture-negative endocarditis, meaning that no microorganisms can be cultured from the blood or tissue samples.12–15 This occurs more frequently in developing countries, where fastidious or rare organisms are more likely to cause human infection. The most common reasons for culture-negative endocarditis in developed countries are administration of antimicrobial agents before cultures are taken, inadequate microbiological techniques, and infection with highly fastidious bacteria or nonbacterial pathogens (e.g., fungi). In all cases of culture-negative NVE, it is important to ascertain that there is no underlying undiscovered infection and to initiate aggressive empiric treatment despite the negative culture data.
DIAGNOSIS
Imaging Studies
Doppler echocardiography is the single most useful diagnostic modality for documenting endocarditis.16–19 Transesophageal echocardiography is the preferred study, with a sensitivity and a specificity of 95% and 90%, respectively.20 Transthoracic echocardiography is less sensitive for endocarditis, but it can be used when transesophageal studies are not feasible. Echocardiography can be used to identify vegetations, paravalvular leaks, abscesses, and fistulae. When there is concern about metastatic or embolic disease, patients with NVE should undergo further imaging with computed tomography (CT) scans of the abdomen or head, or both, as appropriate. Embolic involvement of the brain can also be investigated with magnetic resonance imaging (MRI).21
Duke Criteria
The diagnosis of endocarditis is based on a combination of clinical findings rather than a single test result. Several classification systems for the diagnosis of endocarditis have been published, but the most commonly used is the Duke system.22 First described by Duke University researchers in 1994, this system uses both clinical and pathologic criteria to confirm or reject the diagnosis of infective endocarditis. There are two groups of criteria: major (e.g., positive blood cultures, positive echocardiographic findings) and minor (e.g., fever, predisposing conditions, vascular phenomena, immunologic phenomena, equivocal microbiological findings). On the basis of the number of criteria met, cases are classified into one of three diagnostic categories: low clinical likelihood of endocarditis, possible endocarditis, or definite endocarditis. Definite endocarditis is diagnosed by documentation of two major criteria, of one major and three minor criteria, or of five minor criteria. Cases are considered possible endocarditis when either one major and one minor criterion or three minor criteria are identified. Most authorities accept a recently modified version of the Duke criteria, as shown in Box 80-1.23
Box 80–1 Modified Duke Criteria for Infective Endocarditis
HACEK, group including Haemophilus aphrophilus, Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, and Kingella kingae. From Li JS, Sexton DJ, Mick N, et al. Clin Infect Dis 2000;30:633.
Major Criteria
MANAGEMENT
For the cardiac surgeon, the first management decision is to determine the optimal timing for operation. Should surgery be undertaken now or after appropriate antibiotic treatment? Most indications for surgical intervention are not absolute, and therefore the decision to operate must be based on each individual patient’s clinical status and assessment of the risks and benefits. In general, the more serious and persistent the symptoms and complications of any particular endocarditis case, the sooner surgery should be undertaken. Once the decision to operate has been made, expeditious intervention should occur. If an indication for surgery is identified, it should not be delayed simply to complete antibiotic therapy, as this has been associated with increased mortality.24–26
With either mitral or aortic endocarditis, one common indication for immediate surgery is congestive heart failure. Early surgery in such cases is always warranted, as medical therapy alone is usually ineffective and associated with a poor prognosis. Risk factors for early mortality from NVE include New York Heart Association (NYHA) functional class IV heart failure, cardiogenic shock, advanced age, preoperative acute renal failure, paravalvular extension, and staphylococcal infection.24–26 In 2006, the American College of Cardiology and the American Heart Association (ACC/AHA) issued guidelines on the management of valvular heart disease including recommendations on surgical treatment of NVE, shown in Box 80-2.27 In addition to heart failure, the generally accepted indications for surgery are ongoing sepsis, fungal infection, S. aureus infection, myocardial abscess, and recurrent systemic embolism. For aortic valve endocarditis, conduction abnormalities are a relative indication for surgery as well.
Box 80–2 2006 ACC/AHA Guidelines for the Management of Valvular Heart Disease
ACC/AHA, American College of Cardiology/American Heart Association. From Bonow RO, Carabello BA, Chatterjee K, et al. J Am Coll Cardiol 2006;48:e1.